Detalhe da pesquisa
1.
Antibody-drug conjugates: Smart chemotherapy delivery across tumor histologies.
CA Cancer J Clin
; 72(2): 165-182, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767258
2.
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.
Immunity
; 45(4): 931-943, 2016 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717798
3.
Author Correction: Genomic characterization of metastatic breast cancers.
Nature
; 572(7767): E7, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31308536
4.
Genomic characterization of metastatic breast cancers.
Nature
; 569(7757): 560-564, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31118521
5.
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial.
Br J Cancer
; 130(3): 417-424, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38097741
6.
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.
N Engl J Med
; 382(1): 41-50, 2020 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31751012
7.
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study.
Am J Hematol
; 98(4): 645-657, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36606708
8.
Twitter as a Medical Media Among French Young Oncologists: Results from a National Survey.
J Cancer Educ
; 38(1): 319-324, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34837165
9.
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial.
Lancet Oncol
; 23(9): 1156-1166, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35934010
10.
Late phase 1 studies: concepts and outcomes.
Lancet Oncol
; 22(10): e446-e455, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34592194
11.
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
N Engl J Med
; 378(2): 113-125, 2018 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29151359
12.
Patterns of progression in patients treated for immuno-oncology antibodies combination.
Cancer Immunol Immunother
; 70(1): 221-232, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32700090
13.
Phase 1 study of 2 high dose intensity schedules of the pan-Notch inhibitor crenigacestat (LY3039478) in combination with prednisone in patients with advanced or metastatic cancer.
Invest New Drugs
; 39(1): 193-201, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32915419
14.
Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelin.
Cancer
; 126(22): 4936-4947, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32870522
15.
Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma.
Invest New Drugs
; 38(3): 831-843, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31359240
16.
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.
Nature
; 515(7528): 563-7, 2014 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25428504
17.
A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours.
Br J Cancer
; 120(10): 975-981, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30992546
18.
A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
PLoS Comput Biol
; 14(2): e1005965, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29415044
19.
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Lancet Oncol
; 19(9): 1180-1191, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30120041
20.
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study.
Lancet Oncol
; 19(5): 649-659, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29650362